Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Amniotic Fluid on the Development and Microbial Colonization of the Preterm Intestinal Tract: the AMFIBIE Study

NCT07152106 is registered in ClinicalTrials.gov with Maxima Medical Center as lead sponsor.

NCT NCT07152106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07152106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Amniotic Fluid on the Development and Microbial Colonization of the Preterm Intestinal Tract: the AMFIBIE Study
Lead sponsor
Maxima Medical Center
Phase
Observational
Overall status
Recruiting
Start date
October 14, 2024
Completion date
October 14, 2027
Enrollment
275 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chorioamnionitis, chorioamnionitis affecting fetus or newborn, fetal growth restriction (fgr), necrotizing enterocolitis of newborn, neonatal sepsis, early-onset, neonatal sepsis, late-onset, prematurity complications, preterm birth complication